WORLD Five EU countries against vaccine patent waivers, say focus should be on boosting production

WORLD

Five EU countries against vaccine patent waivers, say focus should be on boosting production

CGTN

17:12, May 08, 2021

FILE PHOTO: A nurse draws a vaccine dose on March 10, 2021 in Kampala, Uganda. /Getty Images

Five European countries on Friday rejected the idea of waiving patent rights on coronavirus vaccines, arguing that the focus instead should be on boosting production of the vital jabs.

Leaders of the 27-nation bloc were scheduled to discuss the patent waiver proposal fronted by South Africa and India and backed by the U.S.

French President Emmanuel Macron noted that patent waivers would not work if countries do not have the capability to produce the vaccines.

"What is the current issue? It is not really about intellectual property. Can you give intellectual property to laboratories that do not know how to produce and will not produce tomorrow?" Reuters quotes Macron to say.

"The main issue for solidarity is the distribution of doses," he added, noting that France was working with Germany on the issue.

The patent waiver proposal is aimed at enabling more countries to manufacture the jabs, thus boosting their availability. Its proponents argue that this would add more firepower in the world's fight against the pandemic.

The proposal's opponents however argue that the waivers would not boost production, as the manufacturing process was still too advanced for poorer countries.

(With input from agencies)

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue